Wheeler CJ - Search Results

1

Thymic CD8+ T cell production strongly influences tumor antigen recognition and age-dependent glioma mortality.

Wheeler CJ, Black KL, Liu G, Ying H, Yu JS, Zhang W, Lee PK. Wheeler CJ, et al. J Immunol. 2003 Nov 1;171(9):4927-33. doi: 10.4049/jimmunol.171.9.4927. J Immunol. 2003. PMID: 14568975 Clinical Trial.

2

Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration.

Yu JS, Wheeler CJ, Zeltzer PM, Ying H, Finger DN, Lee PK, Yong WH, Incardona F, Thompson RC, Riedinger MS, Zhang W, Prins RM, Black KL. Yu JS, et al. Among authors: wheeler cj. Cancer Res. 2001 Feb 1;61(3):842-7. Cancer Res. 2001. PMID: 11221866 Clinical Trial.

3

In situ adenoviral interleukin 12 gene transfer confers potent and long-lasting cytotoxic immunity in glioma.

Liu Y, Ehtesham M, Samoto K, Wheeler CJ, Thompson RC, Villarreal LP, Black KL, Yu JS. Liu Y, et al. Among authors: wheeler cj. Cancer Gene Ther. 2002 Jan;9(1):9-15. doi: 10.1038/sj.cgt.7700399. Cancer Gene Ther. 2002. PMID: 11916248

4

Molecular and functional analysis of tyrosinase-related protein (TRP)-2 as a cytotoxic T lymphocyte target in patients with malignant glioma.

Liu G, Khong HT, Wheeler CJ, Yu JS, Black KL, Ying H. Liu G, et al. Among authors: wheeler cj. J Immunother. 2003 Jul-Aug;26(4):301-12. doi: 10.1097/00002371-200307000-00002. J Immunother. 2003. PMID: 12843792

5

Thymic function and output of recent thymic emigrant T cells during intracranial glioma progression.

Prins RM, Graf MR, Merchant RE, Black KL, Wheeler CJ. Prins RM, et al. Among authors: wheeler cj. J Neurooncol. 2003 Aug-Sep;64(1-2):45-54. doi: 10.1007/BF02700019. J Neurooncol. 2003. PMID: 12952285

6

Intratumoral T cell subset ratios and Fas ligand expression on brain tumor endothelium.

Yu JS, Lee PK, Ehtesham M, Samoto K, Black KL, Wheeler CJ. Yu JS, et al. Among authors: wheeler cj. J Neurooncol. 2003 Aug-Sep;64(1-2):55-61. doi: 10.1007/BF02700020. J Neurooncol. 2003. PMID: 12952286

7

Characterization of defective CD4-CD8- T cells in murine tumors generated independent of antigen specificity.

Prins RM, Incardona F, Lau R, Lee P, Claus S, Zhang W, Black KL, Wheeler CJ. Prins RM, et al. Among authors: wheeler cj. J Immunol. 2004 Feb 1;172(3):1602-11. doi: 10.4049/jimmunol.172.3.1602. J Immunol. 2004. PMID: 14734741

8

Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma.

Yu JS, Liu G, Ying H, Yong WH, Black KL, Wheeler CJ. Yu JS, et al. Among authors: wheeler cj. Cancer Res. 2004 Jul 15;64(14):4973-9. doi: 10.1158/0008-5472.CAN-03-3505. Cancer Res. 2004. PMID: 15256471 Clinical Trial.

9

HER-2, gp100, and MAGE-1 are expressed in human glioblastoma and recognized by cytotoxic T cells.

Liu G, Ying H, Zeng G, Wheeler CJ, Black KL, Yu JS. Liu G, et al. Among authors: wheeler cj. Cancer Res. 2004 Jul 15;64(14):4980-6. doi: 10.1158/0008-5472.CAN-03-3504. Cancer Res. 2004. PMID: 15256472

10

Clinical responsiveness of glioblastoma multiforme to chemotherapy after vaccination.

Wheeler CJ, Das A, Liu G, Yu JS, Black KL. Wheeler CJ, et al. Clin Cancer Res. 2004 Aug 15;10(16):5316-26. doi: 10.1158/1078-0432.CCR-04-0497. Clin Cancer Res. 2004. PMID: 15328167

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

87 results

Search Page

Filters